Morphological Representation of C1q in the Aging Central Nervous System

Abstract

Introduction The complement protein C1q is essential for the innate immune system and neurophysiological and neuropathological processes. To gain more insight into these functions in the CNS, a comprehensive understanding of the morphological representation, especially of its cellular and subcellular target structures, is of great importance.

Methods For a free-floating preparation, the brains of wild-type and ArcAβ mice were cut into 100 μm slices. Living slices were incubated in Ringer’s solution and then fixed in 4% paraformaldehyde (PFA) and stained with different primary and secondary antibodies or methoxy-X04.

Results C1q was abundant in the entire brain. Interestingly, C1q accumulated around cell nuclei, with a perineuronal localization around neuronal somata and a paraneuronal accumulation around non-neuronal cells, e. g., microglia. Moreover, dendritic-like, linear, branched C1q signals were observed in the area between the dentate gyrus and the CA1 region of the hippocampus. Complementary staining revealed an overlap with β-amyloid accumulation reflected by the deposition of C1q within plaques and modified basal C1q levels in the brains of transgenic ArcAβ animals.

Discussion The applied free-floating approach is suitable for C1q immunofluorescence imaging. The consistent colocalization of the complement protein C1q with β-amyloid plaques may reflect an activated immune response, whereas the accumulation of C1q around neuronal structures such as somata and dendrites is still a matter of debate. Intriguingly, C1q surrounds those structures in older brains of both wild-type and ArcAβ mice. Our results also indicate an involvement of C1q in neurophysiological and neurodegenerative processes.

Key words

C1q, Synaptic pruning, neuroinflammation, Alzheimer’s disease, neurodegeneration

Publikationsverlauf

Artikel online veröffentlicht:
16. März 2022

• References

• 1 Janeway CA. The complement system and innate immunity. In: Janeway CA Jr, Travers P, Walport M, Shlomchi MJ. Immunobiology: The Immune System in Health and Disease. New York: Garland Science; 2001. Available from https://www.ncbi.nlm.nih.gov/books/NBK27100/
• 2 Paolicelli RC, Bolasco G, Pagani F. et al. Synaptic pruning by microglia is necessary for normal brain development. Science 2011; 333: 1456-1458
• 3 Benoit ME, Tenner AJ. Complement protein C1q-mediated neuroprotection is correlated with regulation of neuronal gene and microRNA expression. J Neurosci 2011; 31: 3459-3469
• 4 Zabel MK, Kirsch WM. From development to dysfunction: microglia and the complement cascade in CNS homeostasis. Ageing Res Rev 2013; 12: 749-756
• 5 Hong S, Beja-Glasser VF, Nfonoyim BM. et al. Complement and microglia mediate early synapse loss in Alzheimer mouse models. Science 2016; 352: 712-716
• 6 Stephan AH, Madison DV, Mateos JM. et al. A dramatic increase of C1q protein in the CNS during normal aging. J Neurosci 2013; 33: 13460-13474
• 7 Rupprecht C, Rupprecht R, Rammes G. C1q, a small molecule with high impact on brain development: Putative role for aging processes and the occurrence of Alzheimer’s disease. Eur Arch Psychiatry Clin Neurosci 2021; 271: 809-812
• 8 Fonseca MI, Chu SH, Hernandez MX. et al. Cell-specific deletion of C1qa identifies microglia as the dominant source of C1q in mouse brain. J Neuroinflammation 2017; 14: 48
• 9 Lopez ME, Klein AD, Scott MP. Complement is dispensable for neurodegeneration in Niemann-Pick disease type C. J Neuroinflammation 2012; 9: 216
• 10 Rodriguez JJ, Olabarria M, Chvatal A. et al. Astroglia in dementia and Alzheimer’s disease. Cell Death Differ 2009; 16: 378-385
• 11 Matsuoka Y, Picciano M, Malester B. et al. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer’s disease. Am J Pathol 2001; 158: 1345-1354
• 12 Morgan BP. Complement in the pathogenesis of Alzheimer’s disease. Semin Immunopathol 2018; 40: 113-124
• 13 Fonseca MI, Chu SH, Berci AM. et al. Contribution of complement activation pathways to neuropathology differs among mouse models of Alzheimer’s disease. J Neuroinflammation 2011; 8: 4
• 14 Hammond JW, Bellizzi MJ, Ware C. et al. Complement-dependent synapse loss and microgliosis in a mouse model of multiple sclerosis. Brain Behav Immun 2020; 87: 739-750
• 15 Wu T, Dejanovic B, Gandham VD. et al. Complement C3 is activated in human AD brain and is required for neurodegeneration in mouse models of amyloidosis and tauopathy. Cell Rep 2019; 28: 2111-2123
• 16 Petanjek Z, Judas M, Simic G. et al. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc Natl Acad Sci USA 2011; 108: 13281-13286
• 17 Rupprecht TA, Angele B, Klein M. et al. Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system. J Immunol 2007; 178: 1861-1869
• 18 Reichwald J, Danner S, Wiederhold KH. et al. Expression of complement system components during aging and amyloid deposition in APP transgenic mice. J Neuroinflammation 2009; 6: 35
• 19 Kawai S, Kurganov E, Miyata S. Transient increase of microglial C1q expression in the circumventricular organs of adult mouse during LPS-induced inflammation. Cell Biochem Funct 2020; 38: 392-400
• 20 Afagh A, Cummings BJ, Cribbs DH. et al. Localization and cell association of C1q in Alzheimer’s disease brain. Exp Neurol 1996; 138: 22-32
• 21 Head E, Azizeh BY, Lott IT. et al. Complement association with neurons and beta-amyloid deposition in the brains of aged individuals with Down syndrome. Neurobiol Dis 2001; 8: 252-265
• 22 Bialas AR, Stevens B. TGF-β signaling regulates neuronal C1q expression and developmental synaptic refinement. Nat Neurosci 2013; 16: 1773-1782